Figure 15
End of one-years and two-years in HBsAg response, viral breakthrough, viral resistance, adverse events and creatine kinase.
Figure 15 | Virology Journal
End of one-years and two-years in HBsAg response, viral breakthrough, viral resistance, adverse events and creatine kinase.
Virology Journal